One-year tuberculosis risk in rheumatoid arthritis patients starting their first tumor necrosis factor inhibitor therapy from 2008 to 2012 in Taiwan: A nationwide population-based cohort study

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Lim, Chong Hong ^a,b   Lin, Ching Heng ^b   Chen, Der Yuan ^b,c,d,e   Chen, Yi Ming ^b,c,d   Chao, Wen Cheng ^b   Liao, Tsai Ling ^b,d   Chen, Hsin Hua ^b,c,d,e  

^a Rheumatology Unit Department of Internal Medicine Pulau Pinang General Hospital   (Malaysia)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; HYDROXYCHLOROQUINE; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR;

ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; INFECTION RISK; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POPULATION RESEARCH; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; TAIWAN; TUBERCULOSIS; ANTAGONISTS AND INHIBITORS; ARTHRITIS, RHEUMATOID; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

ADALIMUMAB; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; ETANERCEPT; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TAIWAN; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84994719190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0166339     Document Type: Article

References (41)

1. WHO. Global tuberculosis report 2016. 20th edition.Available from: http://www.who.int/tb/publications/global-report/en/.
2. Centers for Disease Control, Ministry of Health and Welfare, R.O.C.(Taiwan). 2015 Centers for disease control annual report. Available from: http://www.cdc.gov.tw/uploads/files/201509/0cc797c3-5252-477f-bd33-91b68c62238d.pdf
3. Arkema EV, Jonsson J, Baecklund E, Bruchfeld J, Feltelius N, Askling J, et al. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments? Annals of the rheumatic diseases. 2015; 74(6):1212-7. doi: 10.1136/annrheumdis-2013-204960 PMID: 24608401.
4. Yeh JJ, Wang YC, Sung FC, Kao CH. Rheumatoid arthritis increases the risk of nontuberculosis mycobacterial disease and active pulmonary tuberculosis. PloS one. 2014; 9(10):e110922. doi: 10.1371/journal.pone.0110922 PMID: 25337995; PubMed Central PMCID: PMCPMC4206451.
5. Yamada T, Nakajima A, Inoue E, Tanaka E, Hara M, Tomatsu T, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Annals of the rheumatic diseases. 2006; 65(12):1661-3. doi: 10.1136/ard.2005.047274 PMID: 16837491; PubMed Central PMCID: PMC1798455.
6. Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis. The Journal of rheumatology. 2003; 30(7):1436-9. PMID: 12858438.
7. Tam LS, Leung CC, Ying SK, Lee GK, Yim CW, Leung YY, et al. Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong - the role of TNF blockers in an area of high tuberculosis burden. Clinical and experimental rheumatology. 2010; 28(5):679-85. PMID: 20822708.
8. Liao TL, Lin CH, Shen GH, Chang CL, Lin CF, Chen DY. Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001-2011. Emerging infectious diseases. 2015; 21(8):1387-95. doi: 10.3201/eid2108.141846 PMID: 26196158; PubMed Central PMCID: PMCPMC4517709.
9. Yasui K. Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-α reagents. Pediatric Rheumatology. 2014; 12(45).
10. Ai JW, Zhang S, Ruan QL, Yu YQ, Zhang BY, Liu QH, et al. The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-alpha Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies. The Journal of rheumatology. 2015; 42(12):2229-37. doi: 10.3899/jrheum.150057 PMID: 26472414.
11. Ke WM, Chen LS, Parng IM, Chen WW, On AW. Risk of tuberculosis in rheumatoid arthritis patients on tumour necrosis factor-alpha inhibitor treatment in Taiwan. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2013; 17(12):1590-5. doi: 10.5588/ijtld.13.0368 PMID: 24200274.
12. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, Group B. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis and rheumatism. 2003; 48(8):2122-7. doi: 10.1002/art.11137 PMID: 12905464.
13. Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Annals of the rheumatic diseases. 2010; 69(3):522-8. doi: 10.1136/ard.2009.118935 PMID: 19854715; PubMed Central PMCID: PMC2927681.
14. Chen YH, Su WJ, Shen GH, Chen DY, Lu LY, Huang DF, et al. Screening and management of tuberculosis infection in patients scheduled for tumor necrosis factor -alpha inhibitors: consensus recommendations from the Taiwan Rheumatology Association. Formosan Journal of Rheumatology. 2012; 26:7.
15. Chen DY, Lu LY, Su WJ, Shen KH, Huang DF, Yu KH, et al. Preliminary Recommendation for Screening of Latent Tuberculosis Infection and Prophylactic/therapeutic Strategies in Rheumatic Patients who are Scheduled for Biologics Therapy. Formosan Journal of Rheumatology. 2011; 25:5.
16. Risk Management Plan for Tumor Necrosis Factor-alpha blocker. Taiwan Food and Drug Adminstration, Department of Health. 2012.
17. Chen DY, Shen GH, Chen YM, Chen HH, Hsieh CW, Lan JL. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFalpha inhibitors: the utility of IFNgamma assay. Annals of the rheumatic diseases. 2012; 71(2):231-7. doi: 10.1136/annrheumdis-2011-200489 PMID: 22021896.
18. National Health Insurance Administration, Ministry of Health and Welfare, Taiwan, R.O.C. (2014). National Health Insurance Annual Report 2014-2015. 2015.
19. Lo HY, Yang SL, Chou P, Chuang JH, Chiang CY. Completeness and timeliness of tuberculosis notification in Taiwan. BMC public health. 2011; 11:915. doi: 10.1186/1471-2458-11-915 PMID: 22151346; PubMed Central PMCID: PMC3260335.
20. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of clinical epidemiology. 1992; 45(6):613-9. Epub 1992/06/01. PMID: 1607900.
21. Chen HH, Huang N, Chen YM, Chen TJ, Chou P, Lee YL, et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Annals of the rheumatic diseases. 2013; 72(7):1206-11. Epub 2012/09/04. doi: 10.1136/annrheumdis-2012-201593 PMID: 22941768.
22. Kourbeti IS, Ziakas PD, Mylonakis E. Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2014; 58(12):1649-57. doi: 10.1093/cid/ciu185 PMID: 24647016.
23. JUNG Seung Min JHJ, PARK Mi-Sun, KWOK Seung-Ki, PARK Kyung-Su, KIM Ho-Youn HWY, PARK Sung-Hwan. Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden. International Journal of Rheumatic Diseases. 2015; 18:323-30. doi: 10.1111/1756-185X.12530 PMID: 25557144
24. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis and rheumatism. 2003; 48(8):2122-7. Epub 2003/08/09. doi: 10.1002/art.11137 PMID: 12905464.
25. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. The New England journal of medicine. 2001; 345(15):1098-104. Epub 2001/10/13. doi: 10.1056/NEJMoa011110 PMID: 11596589.
26. Gomez-Reino JJ, Carmona L, Angel Descalzo M. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis and rheumatism. 2007; 57(5):756-61. Epub 2007/05/29. doi: 10.1002/art.22768 PMID: 17530674.
27. Chiu YM, Lang HC, Lin HY, Yang MT, Fang CH, Yang YW, et al. Risk of tuberculosis, serious infection and lymphoma with disease-modifying biologic drugs in rheumatoid arthritis patients in Taiwan. International journal of rheumatic diseases. 2014; 17 Suppl 3:9-19. doi: 10.1111/1756-185X.12539 PMID: 25496045.
28. Lawn SD, Zumla AI. Tuberculosis. The Lancet. 2011; 378(9785):57-72. doi: 10.1016/s0140-6736(10)62173-3
29. Lee CH, Lee MC, Shu CC, Lim CS, Wang JY, Lee LN, et al. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC infectious diseases. 2013; 13:194. doi: 10.1186/1471-2334-13-194 PMID: 23631563; PubMed Central PMCID: PMCPMC3652752.
30. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS medicine. 2008; 5(7):e152. doi: 10.1371/journal.pmed.0050152 PMID: 18630984; PubMed Central PMCID: PMCPMC2459204.
31. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. The New England journal of medicine. 2004; 350(20):2060-7. doi: 10.1056/NEJMsa031667 PMID: 15141044.
32. Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS. 1993; 7(10):1345-9. PMID: 8267907.
33. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA: the journal of the American Medical Association. 1995; 274(2):143-8. PMID: 7596002.
34. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. The New England journal of medicine. 1989; 320(9):545-50. doi: 10.1056/NEJM198903023200901 PMID: 2915665.
35. Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. Journal of acquired immune deficiency syndromes. 2000; 23(1):75-80. PMID: 10708059.
36. Hu HY, Wu CY, Huang N, Chou YJ, Chang YC, Chu D. Increased risk of tuberculosis in patients with end-stage renal disease: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Epidemiol Infect. 2014; 142(1):191-9. doi: 10.1017/S0950268813000551 PMID: 23510593.
37. Wu VC, Wang CY, Shiao CC, Chang CH, Huang HY, Huang TM, et al. Increased risk of active tuberculosis following acute kidney injury: a nationwide, population-based study. PloS one. 2013; 8(7):e69556. doi: 10.1371/journal.pone.0069556 PMID: 23936044; PubMed Central PMCID: PMCPMC3723893.
38. Chia S, Karim M, Elwood RK, FitzGerald JM. Risk of tuberculosis in dialysis patients: a population-based study. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 1998; 2(12):989-91. PMID: 9869114.
39. Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis and rheumatism. 2006; 55(1):19-26. doi: 10.1002/art.21705 PMID: 16463407.
40. Wang JY, Lee LN, Lai HC, Hsu HL, Liaw YS, Hsueh PR, et al. Prediction of the tuberculosis reinfection proportion from the local incidence. The Journal of infectious diseases. 2007; 196(2):281-8. doi: 10.1086/518898 PMID: 17570116.
41. Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood). 2003; 22(3):61-76. Epub 2003/05/22. PMID: 12757273.